Gastrin is a hormone produced by G-cells in the normal gastric antrum. However, colorectal carcinoma cells may aberrantly produce gastrin and exhibit increased expression of cholecystokinin B (CCK-B)/gastrin receptors. Gastrin is trophic for the normal gastric oxyntic mucosa and exerts a growth-promoting action on gastrointestinal malignancy. Thus, gastrin may act as an autocrine/paracrine or endocrine factor in the initiation and progression of colorectal carcinoma. The molecular mechanisms involved have not been elucidated. Hypergastrinemia induced by Helicobacter pylori infection is associated with increased cyclooxygenase-2 (COX-2) expression in gastric and colorectal tissues, suggesting the possibility that gastrin up-regulates COX-2 expression in these tissues; this has not been confirmed. We report here that gastrin significantly increases the expression of COX-2 mRNA and protein, the activity of the COX-2 promoter, and the release of prostaglandin E 2 from a rat intestinal epithelial cell line transfected with the CCK-B receptor. These actions were dependent upon the activation of multiple MAPK signal pathways, including ERK5 kinase; transactivation of the epidermal growth factor receptor; and the increased expression and activities of transcription factors ELK-1, activating transcription factor-2, c-Fos, c-Jun, activator protein-1, and myocyte enhancer factor-2. Thus, our findings identify the signaling pathways coupling the CCK-B receptor with up-regulation of COX-2 expression. This effect may contribute to this hormone-dependent gastrointestinal carcinogenesis, especially in the colon.
Cyclooxygenase-2 (COX-2)
1 is an inducible enzyme catalyzing the rate-limiting step in prostaglandin synthesis, converting arachidonic acid to prostaglandin H 2 (1) . A large body of genetic and biochemical evidence supports the important role of COX-2 in tumorigenesis, particularly in colorectal cancer (1) . COX-2 is overexpressed in cancer cells and is associated with enhanced invasiveness (1) . However, the molecular mechanisms leading to up-regulation of COX-2 in intestinal cells are not completely understood.
Gastrointestinal hormones regulate gastrointestinal homeostasis by affecting cell proliferation, differentiation, apoptosis, and gene expression. Aberrant control of these biological processes is thought to play an important role in establishment of intestinal neoplasia (2, 3) .
Gastrin is a gastrointestinal hormone that is produced by G-cells in the normal gastric antrum (4) . We (5) and others (6) have shown that expression of cholecystokinin B/gastrin receptors is increased in most colon cancers. Gastrin is trophic for the normal gastric oxyntic mucosa and exerts a growth-promoting action on gastrointestinal malignancy (3, 4, 7, 8) . Ciccotosto et al. (9) reported that 69% of colon cancers contain fully processed gastrin and that 100% have detectable amounts of progastrin, reflecting aberrant production of both gastrin and progastrin by colon cancer. Watson et al. (10, 11) showed that immune neutralization of gastrin or its cognate receptor by antisera inhibits the growth, invasion, and metastasis of colorectal tumors. These findings suggest that gastrin plays a crucial role in colorectal cancer development; however, the molecular mechanisms have not been defined.
Helicobacter pylori infects Ͼ50% of the world population, results in chronic antral gastritis with prolonged hypergastrinemia, and may play a role in development of gastric cancer (12) . Recent evidence shows that 85% of colorectal cancer patients have H. pylori infection and that these patients consistently overexpress COX-2 in the colonic cancer tissue, but not in normal mucosa, where only COX-1 is detected. These data suggest that H. pylori infection may contribute to colorectal carcinogenesis by enhancing colonic expression of gastrin and COX-2 (12, 13) . The fact that H. pylori induced hypergastrinemia is associated with increased COX-2 expression in gastric and colonic tissues suggests that gastrin may regulate COX-2 expression, but this possibility has not been confirmed (14) .
The purpose of this study was to examine whether the activation of the cholecystokinin B receptor (CCK-BR) by gastrin leads to up-regulation of COX-2 expression in intestinal epithelial cells and, if so, to determine the signaling pathways linking CCK-BR to the expression of COX-2. To test this hypothesis, we developed a cell line derived from RIE-1 rat intestinal epithelial cells transfected with human CCK-BR (RIE/ CCKBR cells). Using this cell model, we report here, for the first time, that 1) gastrin significantly stimulates COX-2 expression; 2) this action requires ligand-independent activation of the epidermal growth factor receptor (EGFR); and 3) upregulation of the ERK5/MEF2 pathway is involved. In addition, gastrin activates other MAPK-dependent pathways and increases the expression and activities of other transcription factors such as ELK-1, activating transcription factor-2 (ATF2), c-Fos, c-Jun, and activator protein-1 (AP-1). Thus, our findings identify the signaling pathways coupling CCK-BR with up-regulation of COX-2 expression, which may contribute to gastrin-mediated gastrointestinal carcinogenesis, especially in the colon.
EXPERIMENTAL PROCEDURES
Plasmids-A 2.0-kb EcoRI/HindIII fragment of human full-length CCK-BR cDNA was a gift from Dr. Alan S. Kopin (Tufts University, School of Medicine, Boston, MA) and subcloned into the EcoRI/HindIII sites of the pcDNA3.1 vector (Invitrogen). The vectors MEF2-luc, Gal4-MEF2A, Gal4-MEF2B, Gal4-MEF2C, Gal4-MEF2D, and MEK5AA and a hemagglutinin-tagged form of ERK5 were prepared as described previously (15, 16) . Wild-type Gal4-c-Jun and its mutant were provided by Dr. Michael Karin (University of California, La Jolla, CA). Gal4-ATF2-(1-109) was provided by Dr. Roger J. Davis (Howard Hughes Institute, Worcester, MA). Other plasmids were described previously (17) .
Antibodies-The anti-COX-2 antibodies were obtained from Cayman Chemical Co., Inc. (Ann Arbor, MI). The anti-active ERK1/2 antibody (pTEpY) was purchased from Promega (Madison, WI). Anti-phosphop38 MAPK , anti-phospho-JNK, anti-phospho-ELK-1, and anti-phospho-ATF2 antibodies were obtained from Cell Signaling (Beverly, MA). The anti-phospho-ERK5 antibody was purchased from Sigma. The anti-EGFR and anti-phosphotyrosine (4G10) antibodies were provided by Upstate Biotechnology, Inc. (Lake Placid, NY).
RIE/CCKBR Cell Lines-RIE-1 cells were a gift from Dr. Kenneth D. Brown (Cambridge Research Station, Babraham, Cambridge, UK) and were transfected with human CCK-BR using LipofectAMINE (Invitrogen) according to the manufacturer's recommendations. G418-resistant colonies were selected as described previously (18) . The number of binding sites (B max ) and their binding affinities (K d ) were determined using 125 I-labeled gastrin binding assays as described (19) . Agonistinduced changes in [Ca 2ϩ ] i were detected using the Ca 2ϩ -sensitive dye Fura-2/AM (Molecular Probe, Inc., Eugene, OR) as previously described (17) . Cells were cultured at 37°C in a humidified atmosphere of 95% air and 5% CO 2 in Dulbecco's modified Eagle's medium supplemented with 5% heat-inactivated fetal bovine serum (Hyclone Laboratories, Logan, UT) and 400 g/ml Geneticin (G418, Invitrogen).
RNA Isolation and Northern Blot Analysis-Total cellular RNA was extracted as previously described (17) . RNA samples (30 g/lane) were separated on formaldehyde-containing 1.25% agarose gels and blotted onto Nytran Plus filters (Schleicher & Schü ll). The blots were hybridized with cDNA probes labeled with [␣-32 P]dATP by random primer extension. Specific hybridization was visualized by autoradiography. To ensure RNA integrity and to confirm equal loading between lanes, the filters were stripped and rehybridized with a probe for 18 S rRNA.
Western Blot Analysis-Immunoblot analysis was performed as described previously (17, 18) . The cells were lysed for 30 min on ice in radioimmune precipitation assay (RIPA) buffer consisting of 50 mM Tris-HCl (pH 7.4), 1% Nonidet P-40, 0.25% sodium deoxycholate, 150 mM NaCl, 1 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin, and 1 mM sodium orthovanadate. Cellular proteins were denatured by heating, resolved by SDS-PAGE, transferred to nitrocellulose membranes, and probed with the indicated antibodies and then with peroxidase-coupled secondary antibodies. Proteins were detected using the enhanced chemiluminescence system (ECL, Amersham Biosciences).
Prostaglandin E 2 (PGE 2 ) Assay-RIE/CCKBR cells were plated in 24-well plates. Thirty-six hours later, the medium was replaced with serum-free Dulbecco's modified Eagle's medium. The cells were then incubated with or without gastrin for the indicated times. The medium was collected from each well and analyzed for PGE 2 by enzyme-linked immunosorbent assay (Cayman Chemical Co., Inc.).
Luciferase Assay-RIE/CCKBR cells were seeded in six-well plates at a density of 2 ϫ 10 5 cells/well. After overnight adhesion, cells were transfected with 2 g of promoter-luciferase reporter DNA and 0.02 g of pRL-TKluc vector (Promega) using FuGENE 6 (Roche Molecular Biochemicals). Prior to assaying for luciferase activity, cells were incubated in Dulbecco's modified Eagle's medium without serum (24 h) and treated with gastrin for 6 h. Luciferase activity in 20 l of cell extract was assayed using the Dual-Luciferase assay system (Promega) with a Monolight 2010 luminometer (Analytical Luminescence Laboratory). The activity of the pRL-TKluc plasmid is distinguished from that of the other firefly luciferase reporters and was used to normalize for variation in transfection efficiency.
Electrophoretic Mobility Shift Assay-Nuclear extracts were prepared as previously described (17) . An oligonucleotide corresponding to the AP-1-binding site consensus sequence was purchased from Stratagene (La Jolla, CA). The double-stranded oligonucleotide of the MEF2 DNA-binding site in the mouse COX-2 promoter (CATTTCATTA-AAAATAGAAGAA) was synthesized by Genosys Biotechnologies, Inc. (The Woodlands, TX). The oligonucleotides were end-labeled with [␥-32 P]ATP and T4 polynucleotide kinase. Electrophoretic mobility shift assay reaction mixtures contained 50,000 cpm of 32 P-end-labeld oligonucleotide, 20 g of nuclear protein extract, and 1.0 g of poly(dI⅐dC) (Amersham Biosciences) in a final volume of 20 l. Reaction mixtures were resolved on 4% nondenaturing polyacrylamide gel at 200 V for 2 h. Gels were dried and visualized by autoradiography.
Statistical Analysis-All experiments were repeated on at least three separate occasions. Results from Northern and Western blotting were quantified by densitometry. Values are expressed as means Ϯ S.E. Differences between means were compared using the analysis of variance test and were considered significantly different at p Ͻ 0.05.
RESULTS
RIE/CCKBR Cells-To determine whether gastrin can regulate endogenous COX-2 expression in RIE-1 cells, cells were stably transfected with an expression vector containing a human CCK-BR cDNA downstream of the cytomegalovirus promoter. After selection with G418, surviving cell clones were evaluated for the level of receptor expression using radiolabeled ligand binding and Ca 2ϩ imaging with the Ca 2ϩ indicator dye Fura-2/AM. The binding affinity of 125 I-gastrin was calculated in terms of the equilibrium dissociation constant (K d ) from the Scatchard plot of specific binding data. The clone of RIE/CCKBR cells used in this study exhibits a K d value of 0.3 nM with 8000 binding sites/cell. Fura-2 imaging experiments revealed that Ͼ92 and 97% of these cells exhibited an increase in [Ca 2ϩ ] i upon stimulation with 1 and 100 nM gastrin, respectively ( Fig. 1, B 
-E).
Gastrin Stimulates COX-2 Expression and Activity-Gastrin significantly induced time-and dose-dependent increases in the expression of COX-2 mRNA and protein in RIE/CCKBR cells. Compared with untreated cells, the steady-state COX-2 mRNA levels increased in cells treated with gastrin (100 nM) by 2.8-, 3.8-, 4.5-, 5.6-, and 1.3-fold at 1, 2, 4, 8, and 24 h, respectively ( Fig. 2A) . Gastrin also increased COX-2 mRNA abundance in a dose-dependent fashion. Treatment with 1 and 10 nM gastrin for 8 h revealed 3.2-and 4.8-fold increases in COX-2 mRNA abundance, respectively, whereas 100 and 1000 nM induced maximum responses (6.8-fold) (Fig. 2B) . Moreover, gastrin treatment evoked a time-dependent increase in COX-2 protein levels. Western blots exhibited no detectable expression of COX-2 protein in untreated RIE/CCKBR cells, but showed an increase in COX-2 protein by 6 h, reaching a maximum intensity at 12-24 h after stimulation (Fig. 2C) .
COX converts arachidonic acid, released from the cell lipid bilayer by the action of phospholipase A 2 , to prostaglandin H 2 , the common precursor of all prostaglandins (1). To examine whether increased COX-2 expression is associated with elevated prostaglandin synthesis, the levels of PGE 2 released from RIE/CCKBR cells were measured using an enzyme-linked immunosorbent assay. Compared with untreated control cultures, PGE 2 levels in the medium of RIE/CCKBR cells treated with gastrin rose 1.3-fold at 12 h and continued to increase to 6.2-fold at 48 h (Fig. 2D) .
Gastrin Stimulates COX-2 Promoter Activity-COX-2 expression is controlled by both transcriptional and post-transcriptional mechanisms (17, 20, 21) . To determine whether gastrin regulates COX-2 promoter activity, RIE/CCKBR cells were transfected with different sized fragments of the mouse COX-2 promoter coupled with a luciferase reporter gene. Gas- 2 , and 6 mM glucose, the cells were loaded with 2 mM Fura-2/AM for 50 min at 25°C, washed again, and transferred to a perfusion microincubator equipped with a fluorescent objective and connected to a dual-excitation system in the dark. Single-cell fluorescence following gastrin (G17) treatment was recorded using an intensified charge-coupled device camera (Dage-MTI, Inc., Michigan City, IN) with 340-and 380-nm excitation and 520-nm emission wavelengths. Images were acquired every 8 s, and the 340/380 nm ratio values of the single cell were generated using Image Master software (PTI).
FIG. 2. Gastrin stimulates COX-2 expression and activity in RIE/CCKBR cells.
A, shown is the time course of COX-2 mRNA expression. Subconfluent serum-starved RIE/CCKBR cells were treated with 100 nM gastrin (G17; ϩ) for the indicated times, and the steady-state levels of COX-2 mRNA expression were determined by Northern blotting. B, gastrin treatment for 8 h induced a dose-dependent increase in COX-2 mRNA abundance. C, shown is the time course of COX-2 protein expression. RIE/CCKBR cells were incubated with 100 nM gastrin, lysed in radioimmune precipitation assay buffer for the indicated times, and analyzed by Western blotting as described under "Experimental Procedures." D, gastrin stimulated the release of PGE 2 from RIE/CCKBR cells. E, gastrin stimulated COX-2 promoter activity. Left, shown are the cis-acting transcriptional response elements of the mouse COX-2 promoter and the constructs of three different sized fragments of the mouse COX-2 promoter coupled with a luciferase (Luc) reporter gene. CRE, cAMP-responsive element. Right, COX-2 promoter activity stimulated by gastrin was examined using the Dual-Luciferase assay system in four independent experiments and is expressed relative to control cultures after normalizing the differences in transfection efficiency by the activity of the pRL-TKluc plasmid.
trin (100 nM) evoked a 3.2-fold increase in luciferase activity in cells transiently expressing TIS10L-luc (Ϫ963/ϩ70) compared with untreated control cultures. A 2.0-fold induction was observed when using a shorter fragment of the COX-2 promoter (TIS10Ϫ80luc, Ϫ80/ϩ70). Gastrin did not stimulate an increase in luciferase activity in cells containing the shortest COX-2 promoter construct (TIS10Ϫ40luc, Ϫ40/ϩ70) (Fig. 2E) .
Thus, these data demonstrate that CCK-BR-mediated signaling pathways are linked to regulation of COX-2 promoter activity in RIE/CCKBR cells.
MAPKs Mediate Gastrin-stimulated COX-2 Expression-MAPK signal transduction pathways constitute one of the major mechanisms by which extracellular stimuli are converted into specific nuclear responses. Four families of MAPK kinases have been identified, including the ERKs (which were initially known simply as MAPKs), JNK, p38 MAPK , and big MAPK1 (BMK1 or ERK5). These kinases are regulated by their upstream specific MAPK kinases, i.e. MEK1, MKK4/7, MKK3/6, and MEK5, respectively (22) . To determine whether gastrin activates MAPK pathways in RIE/CCKBR cells, the levels of phosphorylation of the four MAPKs were determined by immunoblotting.
We found that gastrin treatment stimulated the activation all of four MAPKs (Fig. 3) . Western blots of RIE/CCKBR cell extracts, probed with antibodies selective for phosphorylated (activated forms) ERK1 and ERK2, showed that gastrin induced a time-dependent increase in phosphorylated ERK1 and ERK2 (Fig. 3A) . This phosphorylation was increased 1 min after gastrin administration and reached a peak at 5 min before returning to the base-line level at 15 and 30 min. A second peak was detected at 60 min and was maintained at the same level for 120 min (Fig. 3A) . The second peak may result from EGFR transactivation (phosphorylation) induced by gastrin because preincubation with the EGFR tyrosine kinase inhibitor AG1478 prevented the gastrin-elicited second peak (Fig. 3B ), but not the first peak (data not shown), of ERK activation. Moreover, gastrin induced a time-dependent increase in tyrosine phosphorylation of EGFR (Fig. 3C) .
Gastrin also increased the phosphorylation of p38 MAPK in a time-dependent manner. The phosphorylation of p38 MAPK increased from 1 to 30 min and decreased thereafter (Fig. 3D) . In addition, JNK activity was stimulated by gastrin. JNK phosphorylation was first noted at 1 min, reached peak levels at 5-15 min, and then returned to the basal level (Fig. 3E) . The active status of JNK was further confirmed by a transactivation luciferase assay. We cotransfected RIE/CCKBR cells with an expression vector for the transactivation domain of c-Jun fused with the DNA-binding domain of Gal4 together with the Gal4-luc construct, a luciferase reporter gene under the control of five Gal4-responsive elements. In this system, Gal4-c-Jun can transactivate and stimulate luciferase activity only if serines 63 and 73 of c-Jun are phosphorylated by JNK and thus provide an indirect measure of JNK (23) . As shown in Fig. 3F , gastrin induced a 4.2-fold increase in luciferase activity in cells transfected with wild-type Gal4-c-Jun, but not with its mutant (serines 63 and 73 of c-Jun in the Gal4-c-Jun plasmid changed to alanines). In addition, ERK5 may participate in gastrindependent signaling transduction in RIE/CCKBR cells. ERK5, a novel type of MAPK with 816 amino acids, is about twice the size of other MAPKs, is regulated by activation of G protein-coupled receptors (GPCRs) and oxidative stresses, and is phosphorylated by MEK5 (16, 24) . Whether gastrin activates ERK5 has not been reported. Immunoblotting using the anti-phospho-ERK5 antibody demonstrated that ERK5 phosphorylation after gastrin treatment was detected as early as 1 min, continued to increase up to 30 min, and declined subsequently (Fig. 3G) .
To determine whether MAPK activation is required for gastrin-induced COX-2 gene expression, RIE/CCKBR cells were pretreated for 30 min with selective inhibitors of MEK (PD98059) and p38 MAPK (SB203580). PD98059 (10 M) and SB203580 (5 M) significantly suppressed gastrin-stimulated COX-2 mRNA abundance and promoter activity (Fig. 4, A and  B) . Because the gastrin-mediated ERK phosphorylation resulted partly from transactivation of EGFR (Fig. 3, A-C) , we next examined the role of AG1487 in COX-2 protein expression using Western blotting. As shown in Fig. 4C, AG1487 inhibited, but not completely, gastrin-stimulated COX-2 protein levels. Moreover, in cells cotransfected with a vector containing the COX-2 promoter coupled with a luciferase reporter gene and a dominant-negative mutant vector for JNK or for MEK5, we found that these dominant-negative vectors significantly inhibited gastrin-elicited COX-2 promoter activity compared with the control cultures cotransfected with empty vector (Fig. 4D) . Taken together, these results suggest that transactivation of the EGFR-, MEK/ERK1/2-, p38 MAPK -, JNK-, and MEK5/ERK5-dependent pathways is involved in CCK-BR-mediated regulation of COX-2 gene expression.
Gastrin Activates ELK-1, ATF2, and AP-1 Transcription Factors-The COX-2 promoter contains multiple potential cis-activating elements. To date, AP-1, cAMP-responsive element, E-box, NF-IL6 (CAAT/enhancer-binding protein-␤), and NF-B transcriptional elements have been reported to be involved in receptor-mediated COX-2 expression (17, 20, 25) . Additionally, numerous other cis-activating consensus sequences have been identified within the COX-2 promoter, including AP-2, SP-1, MEF2, STAT1, and STAT3 sites (20, 25) . Whether these ciselements contribute to gastrin-induced COX-2 transcription is unknown. In several cell models, gastrin is a potent stimulator of the AP-1 transcription factor complex (26, 27) . The AP-1 complex is composed of either homodimers of Jun protein or heterodimers of Jun and Fos proteins, which bind to a specific DNA consensus sequence (TGA(C/G)TCA) (28) . Electrophoretic mobility shift assay using an end-labeled oligonucleotide probe containing the AP-1-binding consensus sequence showed an increase in AP-1-binding activity with gastrin (Fig. 5A) . The AP-1-binding activity stimulated by gastrin was detected by 2 h, reached a maximum at 4 h, and diminished thereafter. To ensure specificity of binding, a competition experiment was performed using a 100-fold molar excess of unlabeled probe, which effectively competed the protein-DNA band (Fig. 5A,  lane 6) . Gastrin-stimulated expression of c-fos and c-jun mRNAs preceded the increase in AP-1-binding activity. The mRNA abundance of both transcription factors was rapidly increase at 0.5 h and declined after 1-2 h of stimulation (Fig.  5B) . Moreover, RIE/CCKBR cells transfected with luciferase gene reporters driven by either the serum response element located in the c-fos gene promoter or the 12-O-tetradecanoylphorbol-13-acetate response element within the c-jun gene promoter showed 1.8-and 2.2-fold increases in luciferase activity, respectively, compared with untreated cells (Fig. 5C ), indicating that gastrin transactivated the activities of the c-fos and c-jun promoters.
Expression of the c-fos and c-jun genes is regulated, in part, by ternary complex factors and ATF2, respectively. Ternary complex factors belong to the Ets domain family of DNA-binding proteins, including ELK-1, Sap-1A, and Sap-1B. The phosphorylation of ELK-1 or Sap-1 by MAPKs increases its ability to form complexes with the serum response factor and results in serum response element-dependent activation of the c-fos promoter (29, 30) . The phosphorylation of ATF2 by p38 MAPK and JNK increases the 12-O-tetradecanoylphorbol-13-acetate response element-dependent transcriptional activity of c-jun (29) . To determine whether these transcription factors are involved in gastrin signaling, we determined the effect of gastrin on their phosphorylation state using antibodies directed against the phosphorylated (activated) forms of ELK-1 and ATF2. The phosphorylated ELK-1 was detected 1 min after gastrin treatment and was maintained at higher levels at 5-10 min before returning to the base-line level at 15 and 30 min, followed by an increase again at 60 min and a second peak at 90 -120 min (Fig. 6A) . Interestingly, the time course of ELK-1 phosphorylation is parallel to that observed for ERK1/2 phosphorylation induced by gastrin (Fig. 3A) . Gastrin-activated ATF2 was observed within 5 min, reached a maximum at 30 min, and then returned to the basal level (Fig. 6B) . To further confirm these findings, we examined the effect of gastrin on the transactivation of these factors. RIE/CCKBR cells were cotransfected with plasmids carrying genes for fusion proteins, including Gal4-ELK-1, Gal4-Sap-1, and Gal4-ATF2, and the 5ϫGal4-luc reporter genes. As shown in Fig. 6C , ELK-1-and ATF2-dependent (but not Sap-1-dependent) reporter gene expression was activated by gastrin. Together, these results indicate that gastrin activates transcription factors ELK-1 and ATF2, which may participate in the regulation of gastrin-dependent c-fos and c-jun expression in RIE/CCKBR cells.
To ascertain whether AP-1 activation is required for gastrinmediated COX-2 expression, we treated RIE/CCKBR cells with diferuloylmethane (curcumin), which is an inhibitor of AP-1 binding (17, 31) . RIE/CCKBR cells were transiently transfected with a plasmid containing the COX-2 promoter coupled with a luciferase reporter gene, pretreated with or without curcumin for 0.5 h, and then stimulated with 100 nM gastrin for 6 h. The COX-2 promoter activity evoked by gastrin was suppressed by curcumin in dose-dependent fashion, with maximum inhibition at 10 M (Fig. 5D ). In addition, we found that curcumin induced a dose-dependent inhibition of AP-1-binding activity and COX-2 mRNA expression stimulated by gastrin in RIE/CCKBR cells (data not shown). Thus, these findings demonstrate that AP-1 is an important intermediate in gastrin-mediated COX-2 gene expression in RIE/CCKBR cells.
Gastrin Increases Expression and Activation of the MEF2 Transcription Factor-Although extensive studies have established the role of AP-1 complexes and their related transcription factors in transcriptional control, little information is available on the role of the MEF2 proteins. The MEF2 family contains four transcription factors (MEF2A-2D) that mediate the signaling of GPCRs (32) . When RIE/CCKBR cells were transiently transfected with a construct containing the MEF2 DNA-binding sequence upstream of a minimal promoter in the pGL3 reporter plasmid (pGL3-MEF2), gastrin effectively increased the luciferase activity compared with unstimulated control cells (Fig. 6D, second bar) . Moreover, electrophoretic mobility shift assay carried out with a radiolabeled 22-bp oligonucleotide probe corresponding to the MEF2 domain in the COX-2 promoter revealed an increase in MEF2-binding activity in the nuclear extracts of RIE/CCKBR cells treated with gastrin compared with the control culture extracts. The gastrinstimulated MEF2-binding activity reached a maximum between 2 and 4 h, followed by a decrease at 6 h (Fig. 6E) . This protein-DNA binding was completely inhibited by a 100-fold molar excess of unlabeled MEF2 probe (Fig. 6E, lane 7) , but not by the unrelated probe NF-B (lane 6), suggesting that this is a specific MEF2 protein-DNA-binding band. Thus, these complementary approaches using transactivation luciferase and gel shift assays confirm that the MEF2-binding site in the COX-2 promoter could be one target for gastrin-mediated signaling pathways.
To further determine which MEF2 subtypes are activated by gastrin, RIE/CCKBR cells were cotransfected with a pGal4-luc reporter gene construct and an expression plasmid for the Gal4 DNA-binding domain fused with the transactivation domain of MEF2A, MEF2B, MEF2C, or MEF2D (Gal4-MEF2A, Gal4-MEF2B, Gal4-MEF2C, and Gal4-MEF2D, respectively). As shown in Fig. 6D , gastrin significantly increased MEF2B-, MEF2C-, and MEF2D-dependent (but not MEF2A-dependent) reporter gene expression in RIE/CCKBR cells. Numerous factors have been shown to regulate MEF2 activation, such ERK5, p38 MAPK , calmodulin, and SMAD proteins (32, 33) . To address whether MAPKs affect MEF2 expression, we next cotransfected RIE/CCKBR cells with reporter plasmid pGL2-MEF2 and a dominant-negative expression vector of MKK6 (dnMKK6) or a domain-negative MEK5 construct (dnMEK5). As shown in Fig. 6F , the MEF2-dependent luciferase activity elicited by gastrin was partially blocked by cotransfection with dnMKK6 or with a dnMEK5 vector, suggesting that MEF2 may serve as a downstream target of MKK6/p38
MAPK and MEK5/ ERK5 in gastrin-mediated COX-2 expression signaling pathways.
DISCUSSION
Recent reports have demonstrated that hypergastrinemia induced by H. pylori infection is often associated with increased COX-2 expression in gastric and colorectal tissues (12, 13) ; because COX-2 is known to cause tumorigenesis (1), these findings suggest the possibility that COX-2 may mediate gastrin-induced carcinogenesis (12) (13) (14) . To evaluate potential mechanistic links between gastrin-dependent signaling pathways and the regulation of COX-2 expression in intestinal epithelial cells, we developed the RIE/CCKBR cell line. Using this cell model, we report here the first evidence that 1) gastrin significantly stimulates COX-2 expression; 2) this action requires ligand-independent activation of EGFR; and 3) up-regulation of the ERK5/MEF2 pathway is also involved. In addition, gastrin activates ERK1/2, JNK, and p38 MAPK protein kinases. Following MAPK activation, several other transcription factors are up-regulated, including ELK-1, ATF2, c-Fos, c-Jun, and AP-1. The affiliation between the initial biochemical events and downstream transcriptional regulation of COX-2 expression coupled with the effects of related selective inhibitors and dominant-negative plasmids is outlined in Fig. 7 .
The MAPK pathways play a central role in the regulation of COX-2 expression in response to a variety of extracellular stimuli. We have reported that bombesin stimulated COX-2 expression in RIE-1 cells transfected with gastrin-releasing peptide receptor involves both ERK and p38 MAPK (17) . Similarly, ERK and p38 MAPK pathways mediate the induction of COX-2 expression by transforming growth factor-␣ and interferon-␥ in human epidermal keratinocytes and squamous carcinoma cells (34) . JNK and p38
MAPK pathways regulate interleukin-1␤-stimulated COX-2 expression in renal mesangial cells (35) . Regulation of COX-2 by platelet-derived growth factor is mediated through ERK and JNK pathways in NIH3T3 cells (20) , but ERK2 is required for oxytocin-stimulated PGE 2 synthesis in uterine endometrial and amnionic cells (36) . Moreover, ERK, JNK, and p38
MAPK all are involved in the induction of COX-2 expression by physiological hypertonicity in renal medullary collecting duct cells (37) . In the present study, we show that, in addition to ERK, JNK, and p38 MAPK , the ERK5 pathway is required for gastrin-induced COX-2 expression.
Together, these studies demonstrate that MAPK cascades mediate the stimulatory effects of different extracellular stimuli on COX-2 expression in a stimulus-and cell type-specific manner.
Although MAPKs activated by gastrin have been shown in a variety of cell types, the forms and kinetics of MAPK activation after gastrin treatment have not been fully investigated. In AR42J pancreatic acinar and AGS-B gastric cancer cells, ERK activity increased 5 min after gastrin treatment (38, 39) , whereas in Chinese hamster ovary cells and Rat1 fibroblasts transfected with CCK-BR, ERK activity was detected 1-5 and 3-10 min, respectively, after stimulation (40 -42) . In our current study, gastrin-induced phosphorylation of ERK1 and ERK2 increased at 1 min, peaked at 5 min, declined to below basal levels by 30 min, began to rise again by 60 min, and remained at the elevated levels for 120 min after treatment (Fig. 3A) . The second peak of ERKs required EGFR transactivation (Fig. 3, C and D) .
Over the past few years, numerous studies have investigated the role of EGFR in GPCR signal transduction. Daub et al. (43) first identified EGFR as a critical element in endothelin-1-, lysophosphatidic acid-, and thrombin-induced MAPK activation. Currently, EGFR transactivation has become recognized as a key mechanism that couples distinct signal transduction pathways to diverse cellular responses. Various stimuli of GPCRs such as lysophosphatidic acid, carbachol, and bombesin induce the proteolytic processing of the transmembrane pro-HB-EGF precursor to yield mature ligand (HB-EGF) (44) . Gastrin has been reported to induce expression of HB-EGF mRNA, processing of pro-HB-EGF, release of HB-EGF into the medium, and tyrosine phosphorylation of EGFR in the gastric epithelial cell lines RGM1 and AGS (45, 46) . In RIE/CCKBR cells, we found that gastrin failed to produce HB-EGF. 2 Instead, it induced ligand-independent tyrosine phosphorylation of EGFR (Fig. 3C) .
Consistent with this finding, several reports have demonstrated that GPCR-induced EGFR transactivation is exclusively mediated via an intracellular signaling pathway. The cross-signaling mechanism leading to activation of the EGFR kinase may involve protein kinase C or the intracellular tyrosine kinase Src (47, 48) . In our study, gastrin-mediated transactivation of EGFR was inhibited by the selective Src kinase inhibitor PP2, 2 suggesting that Src mediated this effect. Although the functional connection between Src and EGFR is still unclear, Luttrell et al. (49) recently reported that stimulation of the ␤ 2 -adrenergic receptor results in the assembly of a protein complex containing ␤-arrestin, activated Src, and EGFR, with EGFR serving as a scaffold for the GPCR-induced Ras/ERK signaling pathway. Whether a multiprotein complex containing EGFR, Src, and adapter proteins is necessary for gastrindependent EGFR activation is under study in our laboratory.
Although MEF2-binding sequences exist in the COX-2 promoter of human, rat, and mouse, whether this cis-acting factor participates in the regulation of COX-2 expression has not been reported so far. We found that gastrin stimulated MEF2 transcriptional activity using the luciferase assay (Fig. 6D, second  bar) . Gel shift assay further confirmed that gastrin increased MEF2-binding activity (Fig. 6E ). This effect is controlled by the MEK5/ERK5 and MKK6/p38 MAPK pathways (Fig. 6F) . Moreover, dnMEK5 and SB203580 both partially blocked gastrinelicited COX-2 promoter activity (Fig. 4, B and C) , suggesting that the MEK5/ERK5/MEF2 and p38 MAPK /ERK5/MEF2 pathways participate in gastrin-mediated COX-2 expression.
Previous reports have shown that ERK5 and its downstream target MEF2 can be activated by GPCRs (15, 16, 50) . muscarinic acetylcholine receptor and thrombin receptors couple with the G q and G 12/13 family of heterotrimeric G proteins. Stimulation of G q -coupled m1 muscarinic receptors by carbachol potently activates ERK5 kinase and the MEF2 transcription factor (15, 16, 50) , but stimulation of G i -coupled m2 muscarinic receptors has no effect on ERK5 activity. In addition, activation of thrombin receptors coupled with G␣ q and G␣ 12/13 also increase ERK5 activity (50) . These results suggest that receptors coupled with G␣ q and G␣ 12/13 may harbor the ability to transduce a signal to ERK5, whereas G i -coupled receptors do not (15, 16, 50) . Our study shows that activation of CCK-BR, which belongs to the G␣ q -and G␣ 12/13 -coupled receptor family (4), also stimulates the ERK5/MEF2 pathway in intestinal epithelial cells. Thus, this finding confirms and extends the previous reports (15, 16, 50) . In addition, the signaling pathway linking CCK-BR to COX-2 expression is much more complex than initially anticipated, as it involves the integration of numerous MAPK pathways rather than a linear series of sequential events (Fig. 7) . In summary, our results demonstrate that gastrin is a potent stimulator of COX-2 expression in intestinal epithelial cells through receptor-mediated activation of multiple protein kinase pathways and suggest that the upregulation of COX-2 expression induced by gastrin may contribute to this hormone-dependent gastrointestinal carcinogenesis, especially in colon.
